Glenmede Trust CO Na Theravance Biopharma, Inc. Transaction History

Glenmede Trust CO Na

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$14.89 - $20.16 $1,086 - $1,471	-73 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$14.79 - $22.49 $3,268 - $4,970	-221 Reduced 75.17%	73 $1,000
Q2 2020 Aug 14, 2020	BUY	$20.64 - $30.69 $5,139 - $7,641	249 Added 553.33%	294 $5,000
Q4 2019 Feb 12, 2020	SELL	$16.12 - $25.89 $64 - $103	-4 Reduced 8.16%	45 $1,000
Q1 2019 May 14, 2019	SELL	$22.57 - $28.15 $248 - $309	-11 Reduced 18.33%	49 $1,000
Q4 2018 Feb 14, 2019	BUY	$22.52 - $35.07 $1,351 - $2,104	60 New	60 $1,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $629M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.